PB 32 of 2014
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 3)
National Health Act 1953
I, ADRIANA PLATONA,  Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated           11                April 2014
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health
 
 
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2014 (No. 3).
         (2)   This Determination may also be cited as PB 32 of 2014.
2              Commencement
                This Determination commences on 1 May 2014.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 1, after item dealing with Amylopectin, modified long chain
 
Omit
 
Anakinra
 
[2]     Schedule 1, after item dealing with Methylnaltrexone
 
Omit
 
Methysergide
 
[3]     Schedule 1, after item dealing with Penicillamine
 
Omit
 
Pergolide
 
[4]     Schedule 1, after item dealing with Pizotifen
 
Insert
 
Plerixafor
 
[5]     Schedule 1, after item dealing with Salmeterol
 
Insert
 
Sapropterin